Retrospective Cohort Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Oct 26, 2024; 16(10): 574-579
Published online Oct 26, 2024. doi: 10.4330/wjc.v16.i10.574
Percutaneous decannulation of extracorporeal membrane oxygenation using MANTA device: A real-world single-center experience
Ioannis Milioglou, Alice Qian, Pedro Rafael Vieira de Oliveira Salerno, Gabriel Tensol Rodrigues Pereira, Luis Augusto Palma Dallan, Kelsey E Gray, Michael Morrison, Yasir Abu-Omar, Mohammad Eldiasty, Cristian Baeza
Ioannis Milioglou, Alice Qian, Pedro Rafael Vieira de Oliveira Salerno, Gabriel Tensol Rodrigues Pereira, Luis Augusto Palma Dallan, Department of Cardiology, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, United States
Kelsey E Gray, Michael Morrison, Yasir Abu-Omar, Mohammad Eldiasty, Cristian Baeza, Department of Surgery, University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States
Author contributions: Milioglou I, Qian A, Salerno PRVO and Pereira GTR gathered and analyzed data; Milioglou I and Qian A contributed to the writing of the manuscript; Palma Dallan LA, Gray KE, Morrison M helped with the supervision of data analysis and gathering; Abu-Omar Y, Eldiasty M and Baeza C were responsible for the overall supervision of all steps of this research project.
Institutional review board statement: IRB approval was obtained for the conduction of this study.
Informed consent statement: No need for informed consent for this project given IRB approval and anonymized data presentation.
Conflict-of-interest statement: No conflict of interest is declared by the authors of this manuscript.
Data sharing statement: The article's data will be shared on reasonable request to the corresponding author.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ioannis Milioglou, MD, Doctor, Department of Cardiology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, United States. ioannismilioglou@gmail.com
Received: April 25, 2024
Revised: August 12, 2024
Accepted: September 11, 2024
Published online: October 26, 2024
Processing time: 175 Days and 10.4 Hours
Core Tip

Core Tip: The MANTA vascular closure device offers a novel approach to achieving hemostasis after large-bore femoral access procedures, particularly in complex interventions like transcatheter aortic valve replacement and endovascular aneurysm repair. This single-center study assessed the use of MANTA for percutaneous decannulation in 19 patients undergoing venoarterial extracorporeal membrane oxygenation. The device achieved rapid hemostasis in most cases, though some patients experienced late bleeding or ischemic complications. Despite these challenges, MANTA allowed for bedside decannulation, reducing the need for operating room resources. While promising, the study's small size and lack of a comparison group suggest that further research is needed to validate these findings.